Valneva SE (VALN) Notes Payables (2020 - 2023)
Valneva SE (VALN) posted Notes Payables of $15.2 million for Q1 2023, up 28.62% sequentially from $11.8 million in Q4 2022, and up 15.42% YoY from $13.2 million in Q1 2022.
Analysis
Valneva SE (VALN) Notes Payables (2020 - 2023) Analysis & Trends
Valneva SE has reported Notes Payables for 4 years, with the latest figure at $15.2 million in Q1 2023.
- Quarterly Notes Payables rose 15.42% year-over-year to $15.2 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $15.2 million (up 15.42% YoY) and the FY2022 annual result came in at $12.2 million, up 45.12% from the prior year.
- Notes Payables grew to $15.2 million in Q1 2023 per VALN's latest filing, from $11.8 million in the prior quarter.
- Over five years, Notes Payables peaked at $15.2 million in Q1 2023 and troughed at $8.1 million in Q4 2021.
- A 4-year average of $11.7 million and a median of $12.3 million in 2022 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2021 and 2022: Notes Payables dropped 2.42% in 2021, then surged 45.32% in 2022.
- Over 4 years, Notes Payables stood at $8.3 million in 2020, then decreased by 2.42% to $8.1 million in 2021, then jumped by 45.32% to $11.8 million in 2022, then rose by 28.62% to $15.2 million in 2023.
- According to Business Quant data, Notes Payables over the past three periods registered $15.2 million, $11.8 million, and $12.6 million for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Valneva SE | 578.54 Mn | 437.28 Mn | 1.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 15.20 Mn |
| Dec 31, 2022 | 11.81 Mn |
| Sep 30, 2022 | 12.60 Mn |
| Jun 30, 2022 | 12.32 Mn |
| Mar 31, 2022 | 13.17 Mn |
| Dec 31, 2021 | 8.13 Mn |
| Dec 31, 2020 | 8.33 Mn |